Lippincott ^® NursingCenter ^®

Departments

• Free

  3 Questions on... The New Way(s) to Get Oncology Drugs Approved: With Suparna B. Wedam, MD, Medical Officer at the FDA

  Sarah DiGiulio

• Free

  Approval for Optune Device for Glioblastoma
• Free

  FDA Approves New Oral Drug for Advanced Colorectal Cancer
• Free

  FDA Breakthrough Therapy Designation to Abemaciclib for Breast Cancer
• Free

  More Work, Less Pay for Cancer Care Practices

  Lola Butcher

• Free

  New Potent Treatments for Progressing Neuroendocrine Tumors

  Ed Susman

• Free

  Novel Conjugate Promising for Small Cell Lung Cancer

  Ed Susman

• Free

  Opdivo-Yervoy Combination Approved for Melanoma—First Combination-Immunotherapy Regimen for Cancer
• Free

  Orphan Drug Status to Sarcoma Drug
• Free

  Shop Talk
• Free

  Simone's OncOpinion: Operational Excellence and Best Practices Are Not Enough

  Joseph V. Simone MD

• Free

  Welcoming Hagop Kantarjian, MD!
• Buy

  Access to Palliative Care Improving, But Major Geographic Gaps Remain

  Peggy Eastman

• Buy

  Advanced Melanoma: Continuing Evidence for Superiority of Dual-Treatment Approach

  Ed Susman

• Buy

  Brentuximab Induces ‘Reliable Responses’ in CD30+ CTCL

  Mark L. Fuerst

• Buy

  Earlier CTCL Diagnosis with TCR Sequencing
• Buy

  Follicular Lymphoma: Key Clinical Sign

  Mark L. Fuerst

• Buy

  Lymphoma Linked to Q Fever Bacterium; Screening Urged
• Buy

  NCI's Patient Symptom Reporter Proven Accurate, Usable, Helpful

  Kurt Samson

• Buy

  Nilotinib and High-Dose Chemotherapy Promising for Ph+ ALL

  Heather Lindsey

• Buy

  POINT-COUNTERPOINT: Is There a Role for Adjuvant Oxaliplatin in Rectal Cancer? Great Debates & Updates in GI Malignancies Meeting

  Mark L. Fuerst

• Buy

  Single-Agent Activity for HDAC Inhibitor in Difficult-to-Treat PTCL

  Mark L. Fuerst

• Buy

  Survival Benefits for Low-Dose Aspirin in GI Cancers

  Ed Susman

• Buy

  The Road to Stroma-Directed and Immunotherapy in Pancreatic Cancer

  Robert H. Carlson